CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

GLP-1 medications can help fill that gap, not just by supporting weight loss but by helping rebuild metabolic resilience. Unfortunately, for many women, the real barrier isn’t access. It’s shame.

A new oral drug may be able to treat type 2 diabetes and obesity without impacting muscle mass as an alternative to GLP-1 drugs such as Ozempic, the results of a phase 1 clinical trial suggest.

On average, surgical patients lost 58 pounds (around 24% of their total weight) by the end of year two, whereas GLP-1 patients on average lost 12 pounds (around 4.7% of their total weight)—a ...

Tennessee Attorney General Jonathan Skrmetti has raised concerns about the influx of counterfeit GLP-1 drugs, widely used for weight loss, from at least three countries.

Increased use of GLP-1 drugs for weight loss has led to a rise in body lift surgeries to remove excess skin. To stream KHOU 11 on your phone, you need the KHOU 11 app. Download the KHOU 11 app ...

Patients on continuous GLP-1 therapy for a full year lost more weight, but significantly less than bariatric surgery patients (7% total weight loss). "Clinical trials show weight loss between 15% ...